documents: FDA-2009-P-0597-0019
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-P-0597-0019 | FDA | FDA-2009-P-0597 | Tab 32/Exhibit 32 - "FDA/CDER Response to Wyeth-Ayerst Research, March 1, 1999, re Docket No. 97P-0386/CP1" - [GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition] | Supporting & Related Material | BKG-Background Material | 2009-12-29T05:00:00Z | 2009 | 12 | 2009-12-30T00:43:03Z | 0 | 0 | 0900006480a6cb3c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref